Diabetes and Obesity Drug Market Set to More Than Double, Strategists Say
Strategists forecast that the market for diabetes and obesity treatments will more than double soon, but not all manufacturers will benefit. The article highlights three stocks, including Eli Lilly, that investors can use to bet on the growth of weight‑loss drugs.